Clinical Trial Update: Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED) [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing desloratadine, fexofenadine 180 mg, and placebo for seasonal allergic rhinitis, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Allegra (fexofenadine)
• Clarinex (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED